Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Duck adenovirus 1, commonly known as Egg drop syndrome virus (EDSV), is a non-enveloped, double-stranded DNA virus belonging to the genus Atadenovirus. It is the primary causative agent of Egg drop syndrome '76 (EDS '76), a significant disease in poultry characterized by a sudden drop in egg production and the production of soft-shelled or shell-less eggs in otherwise healthy-looking birds. The virus is unique among adenoviruses for its ability to hemagglutinate avian erythrocytes, a property mediated by its fiber protein which facilitates attachment to host cell receptors. While the virus itself is a pathogen rather than a therapeutic target, its structural proteins—particularly the fiber and hexon proteins—are the primary targets for veterinary vaccine development. Control of the virus is primarily achieved through the administration of inactivated oil-emulsion vaccines or recombinant subunit vaccines designed to elicit neutralizing antibodies that block viral entry and systemic spread.
Vaccines induce neutralizing antibodies against the viral fiber and hexon proteins to prevent viral attachment and entry into host cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Duck adenovirus 1 (DAdV-1).